Illustration: Sarah Grillo/Axios

Ex-Juul CEO Kevin Burns is in advanced talks to join SoftBank-backed digital pharmacy Alto, Axios has learned from multiple sources.

Why it matters: He'd be going from a company that was the scourge of public health officials to one that seeks to become an integral part of America's health care delivery system.

Résumé: Burns was a private equity executive with TPG Capital until leaving in 2014 to become president and COO of Greek yogurt company Chobani. He took over e-cigarette maker Juul in late 2017, before stepping down last September.

  • During his time at Juul, the company faced increased regulatory scrutiny and product bans. He also oversaw its sale of a 35% stake for $12.8 billion to Altria, which since has turned into an albatross around Altria's balance sheet.

Alto Pharmacy was founded in 2015 by Matt Gamache-Asselin, and operates as a digital drug distribution platform whose rivals include Amazon's PillPack.

  • It has raised around $350 million in venture capital, from firms like SoftBank Vision Fund, Jackson Square Ventures, Greenoaks Capital Partners, Olive Tree Capital, and Zola Global. The SoftBank investment was tranched-out, with the second piece coming within the past few weeks.
  • Gamache-Asselin and Burns first began talking as part of a COO search, but one of the job titles now being discussed is co-CEO. A formal board vote is likely within days.

The bottom line: Alto is betting that Burns' operational value will outweigh any blowback the decision prompts from customers, partners and employees.

Go deeper: Altria lost $8.6 billion on its Juul investment in just 14 months

Go deeper

Virtual school is another setback for struggling retail industry

Illustration: Annelise Capossela/Axios

A virtual school year will likely push retailers even closer to the brink.

Why it matters: Back-to-school season is the second-biggest revenue generating period for the retail sector, after the holidays. But retailers say typical shopping sprees will be smaller with students learning at home — another setback for their industry, which has seen a slew of store closures and bankruptcy filings since the pandemic hit.

47 mins ago - Health

The pandemic hasn't hampered the health care industry

Illustration: Rebecca Zisser/Axios

The economy has been tanking. Coronavirus infections and deaths have been rising. And the health care industry is as rich as ever.

The big picture: Second-quarter results are still pouring in, but so far, a vast majority of health care companies are reporting profits that many people assumed would not have been possible as the pandemic raged on.

Column / Harder Line

How climate and business woes are sinking a natural-gas project

Illustration: Annelise Capossela/Axios

The Trump administration recently touted its approval of America’s first terminal on the West Coast to export liquefied natural gas. There’s just one problem: it probably won’t be built.

Why it matters: The project in southern Oregon faces political and business hurdles serious enough that those who are following it say it will be shelved. Its problems embody the struggles facing a once-promising sector that's now struggling under the weight of the pandemic and more.